Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

计划入组 1,520 人 · 首次发布于 2007 年 6 月 7 日

Prevention ICONA Dedicated Ensemble

计划入组 5,000 人 · 首次发布于 2025 年 9 月 22 日

ICON8: Weekly Chemotherapy in Ovarian Cancer

计划入组 1,485 人 · 首次发布于 2012 年 7 月 31 日

L-ICON3

ICON-4

Norovirus GI.4/GII.4 Bivalent VLP Vaccine (Icon Genetics GmbH)

Icon Energy

Egypt

Icon PLC

Ireland

Icon Genetics GmbH

Germany

Real-World Study Confirms Bevacizumab Benefits Limited to High-Risk Epithelial Ovarian Cancer Patients

Corin's Icona Femoral Stem Receives FDA Clearance for Direct Anterior Total Hip Arthroplasty

Corin Receives FDA Clearance for Icona Femoral Stem in Total Hip Arthroplasty